These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39028654)

  • 61. Addiction Consultation Services for Opioid Use Disorder Treatment Initiation and Engagement: A Randomized Clinical Trial.
    McNeely J; Wang SS; Rostam Abadi Y; Barron C; Billings J; Tarpey T; Fernando J; Appleton N; Fawole A; Mazumdar M; Weinstein ZM; Kalyanaraman Marcello R; Dolle J; Cooke C; Siddiqui S; King C
    JAMA Intern Med; 2024 Sep; 184(9):1106-1115. PubMed ID: 39073796
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Methadone Initiation in the Emergency Department for Opioid Use Disorder.
    Wolfson D; King R; Lamberson M; Lyttleton J; Waters CT; Schneider SH; Porter BA; DeWitt KM; Jackson P; Stevens MW; Brooklyn J; Rawson R; Riser E
    West J Emerg Med; 2024 Sep; 25(5):668-674. PubMed ID: 39319796
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comprehensive analysis of discharge reasons from methadone outpatient treatment programs.
    Andraka-Christou B; Totaram R; Nguyen TD
    Am J Addict; 2022 Nov; 31(6):508-516. PubMed ID: 35996855
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Variation in Use of Medications for Opioid Use Disorder in Critically Ill Patients Across the United States.
    Feeney ME; Law AC; Walkey AJ; Bosch NA
    Crit Care Med; 2024 Jul; 52(7):e365-e375. PubMed ID: 38501933
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Gender disparities in opioid treatment progress in methadone versus counseling.
    Guerrero E; Amaro H; Kong Y; Khachikian T; Marsh JC
    Subst Abuse Treat Prev Policy; 2021 Jun; 16(1):52. PubMed ID: 34162420
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule.
    Laks J; Kehoe J; Farrell NM; Komaromy M; Kolodziej J; Walley AY; Taylor JL
    Addict Sci Clin Pract; 2021 Dec; 16(1):73. PubMed ID: 34961554
    [TBL] [Abstract][Full Text] [Related]  

  • 67. County-level sociodemographic differences in availability of two medications for opioid use disorder: United States, 2019.
    Corry B; Underwood N; Cremer LJ; Rooks-Peck CR; Jones C
    Drug Alcohol Depend; 2022 Jul; 236():109495. PubMed ID: 35605533
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessment of the Patient Protection and Affordable Care Act's Increase in Fees for Primary Care and Access to Care for Dual-Eligible Beneficiaries.
    Fung V; Price M; Hull P; Cook BL; Hsu J; Newhouse JP
    JAMA Netw Open; 2021 Jan; 4(1):e2033424. PubMed ID: 33475756
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17.
    Lim S; Cherian T; Katyal M; Goldfeld KS; McDonald R; Wiewel E; Khan M; Krawczyk N; Braunstein S; Murphy SM; Jalali A; Jeng PJ; MacDonald R; Lee JD
    Addiction; 2023 Mar; 118(3):459-467. PubMed ID: 36305669
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of Driving Times to Opioid Treatment Programs and Pharmacies in the US.
    Kleinman RA
    JAMA Psychiatry; 2020 Nov; 77(11):1163-1171. PubMed ID: 32667648
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts.
    Kimmel SD; Walley AY; White LF; Yan S; Grella C; Majeski A; Stein MD; Bettano A; Bernson D; Drainoni ML; Samet JH; Larochelle MR
    JAMA Netw Open; 2024 Jul; 7(7):e2421740. PubMed ID: 39046742
    [TBL] [Abstract][Full Text] [Related]  

  • 72. OUD MEETS: A novel program to increase initiation of medications for opioid use disorder and improve outcomes for hospitalized patients being discharged to skilled nursing facilities.
    Tassey TE; Ott GE; Alvanzo AAH; Peirce JM; Antoine D; Buresh ME
    J Subst Abuse Treat; 2022 Dec; 143():108895. PubMed ID: 36215913
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Simulated impact of mobile opioid treatment program units on increasing access to methadone for opioid use disorder.
    Gibbons JB; Li W; Stuart EA; Saloner B
    Health Serv Res; 2024 Oct; 59(5):e14271. PubMed ID: 38191857
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Medicaid Coverage for Methadone Maintenance and Use of Opioid Agonist Therapy in Specialty Addiction Treatment.
    Saloner B; Stoller KB; Barry CL
    Psychiatr Serv; 2016 Jun; 67(6):676-9. PubMed ID: 26927578
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prescription opioid use patterns, use disorder diagnoses and addiction treatment receipt after the 2014 Medicaid expansion in Oregon.
    Springer R; Marino M; Bailey SR; Angier H; O'Malley JP; Hoopes M; Lindner S; DeVoe JE; Huguet N
    Addiction; 2019 Oct; 114(10):1775-1784. PubMed ID: 31106483
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adapting methadone inductions to the fentanyl era.
    Buresh M; Nahvi S; Steiger S; Weinstein ZM
    J Subst Abuse Treat; 2022 Oct; 141():108832. PubMed ID: 35870437
    [TBL] [Abstract][Full Text] [Related]  

  • 77. "Get in and get out, get on with life": Patient and provider perspectives on methadone van implementation for opioid use disorder treatment.
    Suen LW; Steiger S; Shapiro B; Castellanos S; Joshi N; Lambdin BH; Knight KR
    Int J Drug Policy; 2023 Nov; 121():104214. PubMed ID: 37778132
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Access to Medications for Opioid Use Disorder and Associated Factors Among Adolescents and Young Adults: A Systematic Review.
    Pilarinos A; Bromberg DJ; Karamouzian M
    JAMA Pediatr; 2022 Mar; 176(3):304-311. PubMed ID: 34870707
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes From an 18-Month Study of Patients in Treatment for Opioid Use Disorder.
    Dever JA; Hertz MF; Dunlap LJ; Richardson JS; Wolicki SB; Biggers BB; Edlund MJ; Bohm MK; Turcios D; Jiang X; Zhou H; Evans ME; Guy GP
    Public Health Rep; 2024; 139(4):484-493. PubMed ID: 38268479
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Initiation and Receipt of Medication for Opioid Use Disorder Among Adolescents and Young Adults in 4 State Medicaid Programs in 2018: Improving Medicaid Quality Metrics.
    Lynch V; Clemans-Cope L
    Subst Use Addctn J; 2024 Jul; 45(3):434-445. PubMed ID: 38294428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.